Topical tacalcitol and 308-nm monochromatic excimer light: A synergistic combination for the treatment of vitiligo

Photodermatology Photoimmunology and Photomedicine

Volumn 22, Issue 6, 2006, Pages 310-314

  Lu Yan, Tang ^a   Wen Wen, Fu ^a   Lei Hong, Xiang ^a   Yi, Jin ^a   Zhi Zhong, Zheng ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

308 nm MEL; Tacalcitol; Vitiligo

Indexed keywords

CALCIPOTRIOL; DRUG VEHICLE; TACALCITOL;

ADOLESCENT; ADULT; AGED; ARTICLE; CALCULATION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REDUCTION; ERYTHEMA; EXCIMER LASER; FEMALE; HUMAN; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PRURITUS; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SKIN DEFECT; SKIN EXAMINATION; SKIN PIGMENTATION; STATISTICAL SIGNIFICANCE; THERAPY EFFECT; VITILIGO; XEROSIS;

ADOLESCENT; ADULT; AGED; CHILD; DERMATOLOGIC AGENTS; DIHYDROXYCHOLECALCIFEROLS; FEMALE; HUMANS; LASER THERAPY, LOW-LEVEL; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; RADIATION DOSAGE; SEVERITY OF ILLNESS INDEX; SKIN PIGMENTATION; TREATMENT OUTCOME; ULTRAVIOLET THERAPY; VITILIGO;

EID: 33750819706     PISSN: 09054383     EISSN: 16000781     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2006.00250.x     Document Type: Article

References (20)

1. Leone G, Iacovelli P, Paro Vidolin A, Picardo M. Monochromatic excimer light 308 nm in the treatment of vitiligo: A pilot study. J Eur Acad Dermatol Venereol 2003; 17: 531-537.
2. Spencer JM, Nossa R, Ajmeri J. Treatment of vitiligo with the 308-nm excimer laser: A pilot study. J Am Acad Dermatol 2002; 46: 727-731.
3. Ostovar N, Passeron T, Zakaria W, et al. Treatment of vitiligo by 308-nm excimer laser: An evaluation of variables affecting treatment response. Lasers Surg Med 2004; 35: 152-156.
4. Suhail M, James M, Mark L. The use of the 308-nm excimer laser for the treatment of vitiligo. Dermatol Surg 2004; 30: 983-986.
5. Thierry P, Nima O, Wassim Z, et al. Topical tacrolimus and the 308-nm excimer laser a synergistic combination for the treatment of vitiligo. Arch Dermatol 2004; 140: 1065-1069.
6. Brown AJ. Vitamin D analogues. Am J Kidney Dis 1998; 32: 525-539.
7. Abdel-Malek ZA, Ross R, Trinkle L, Swope V, Pike JW, Nordlund JJ. Hormonal effects of vitamin D3 on epidermal melanocytes. J Cell Physiol 1988; 136: 273-280.
8. Katayama I, Ashida M, Maeda A, Eishi K, Murota H, Bae SJ. Open trial of topical tacalcitol [1 alpha 24(OH) 2D3] and solar irradiation for vitiligo vulgaris: Upregulation of c-Kit mRNA by cultured melanocytes. Eur J Dermatol 2003; 13: 372-376.
9. Jimbow K. Dermatologic therapy. Dermatol Clin 1998; 14: 399-407.
10. Parsad D, Saini R, Vernma N. Combination of PUVA sol and topical calcipotriol in vitiligo. Dermatology 1998; 197: 167-170.
11. Ermics O, Alpsoy E, Cetin L, Yilmaz E. Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study. Br J Dermatol 2001; 145: 472-475.
12. Ameen M, Exarchou V, Chu AC. Topical calcipotriol as monotherapy and in combination with psoralen plus ultraviolet A in the treatment of vitiligo. Br J Dermatol 2001; 145: 476-479.
13. Simin A, Sedef R, Gonca B, AySen K, Fikret K. No additional effect of topical calcipotriol on narrow-band UVB phototherapy in patients with generalized vitiligo. Photodermatol Photoimmunol Photo 2005; 21: 79-83.
14. Chiaverini C, Passeron T, Ortonne JP. Treatment of vitiligo by topical calcipotriol. J Eur Acad Dermatol Venereol 2002; 16: 137-138.
15. Baysal V, Yildirim M, Erel A, Kesici D. Is the combination of calcipotriol and PUVA effective in vitiligo? J Eur Acad Dermatol Venereol 2003; 17: 299-302.
16. Schallreuter KU, Pittelkoe MR. Defective calcium uptake in keratinocyte cell culture from vitiliginous skin. Arch Dermatol Res 1988; 280: 137-139.
17. Schallreuter KU, Pittelkoe MR, Swanson NN. Defective calcium transport in vitiliginous melanocytes. Arch Dermatol Res 1996; 228: 11-13.
18. Abdel-Malek ZA, Ross R, Trinkle L, Swope V, Pike JW, Nordlund JJ. Hormonal effects of vitamin D3 on epidermal melanocytes. J Cell Physiol 1988; 136: 273-280.
19. Milde P, Hauser U, Simon T, et al. Expression of 1,25-dihydroxyvitamine D3 receptors in normal and psoriatic skin. J Invest Dermatol 1991; 97: 230-239.
20. Hofer A, Hassan AS, Legat FJ, Kerl H, Wolf P. Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients. Br J Dermatol 2005; 152: 981-985.